NASDAQ NMS - GLOBAL MARKET · FTH
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Faeth Therapeutics, Inc

Faeth Therapeutics, Inc

Biotechnology
$25.61
Card
Relationship Map

Follow $FTH

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $FTH by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
FTH
Faeth Therapeutics, Inc
Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

47/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 8 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FTH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FTH catalysts
About Faeth Therapeutics, Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
29
Country
US

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$25.61
Last session
Day high
$25.61
Last session
Day low
$25.61
Last session
Previous close
$25.61
52W high
$40.05
-36.05% from high
52W low
$14.53
43% of range
Market cap
$661.8M
EPS
$-141.6484
Beta
0.00
Shares out
25.8M
Avg volume
395.7K
VWAP
$25.61
Last session
Price history computed in-house
1W
-9.66%
1M
-29.10%
3M
-29.18%
SMA 50 $31.63 · below
SMA 200 Not reported · Not reported
52W position 43%

FTH overview

Veridion Score
47
Registered · 2026-10-08
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FTH.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FTH Form 4 filings
Public disclosures

Congress activity in FTH

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

FTH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FTH in this window.
Lobbying spend

FTH lobbying filings, year to date.

Registered lobbying filings matched to Faeth Therapeutics, Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FTH in this window.
Loading news for FTH
Analyst ratings
Sovereign unlock shows live analyst consensus for FTH.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.